According to Market Research Future (MRFR) Analysis – Biosimulation Market is growing at a CAGR of 15.9% during the forecast period 2019 to 2025. The global market industry is segmented by product, application, end users, delivery model, and region.
First Light Biosciences, Inc. (First Light Biosciences) is a medical diagnostic products provider. It develops products based on its proprietary multiPath technology.
Imperial Medical Technologies, Inc(IMT) is a medical equipment manufacturer. The company develops, manufactures, tests, distributes and sells ophthalmic products.
Alafair Biosciences, Inc.( Alafair) is a medical equipment company. It develops cross-linked polysaccharide hydrogel films to address the post-surgical complication of unwanted soft tissue attachments or tethering between opposing tissue surface. Alafair’s initial product is a film that shows superior handling and mechanical properties.
This report provides comprehensive information on the current therapeutic developmental pipeline of 3-V Biosciences Inc. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/3-v-biosciences-inc-product-pipeline-review-2015-market/enquire-about-report
The global rapid influenza diagnostics market is anticipated to grow on account of growing prevalence of influenza coupled with rising awareness across the developed and emerging economies.
CellScope, Inc(CellScope) is a medical device company. It offers two products,namely, smart otoscope and smart dermascope. Its smart otoscope assists pediatricians to increase the level of care by creating a visual history of the middle ear.
Endoscape, Inc. (Endoscape) is a pharmaceutical company. The company plans to bring colonoscopy, the Gold Standard of colon cancer screening, to people through the development of novel products and services for a milder colon preparation and colonoscopy procedure.
BioSET, Inc (BioSET) is a medical equipment as well as drug manufacturer company. The company has expertise in developing orthobiologic devices. Its products are next-generation combination devices that couples with bioactive peptides with tissue-specific scaffolds. Its main product is AMPLEX device which is a combination of the B2A peptide and a synthetic ceramic scaffold with chemical properties similar to that of native bone.
Castle Biosciences Incorporated (Castle Biosciences) is a cancer diagnostics company. The company works with cancer institution to in license propietary technologies and complete development and validation. Castle Biosciences product include DecisionDx-UM test. The DecisionDx-UM test measures the gene expression profile, also called GEP or molecular signature of an individuals tumor and identifies the likelihood of metastasis. The compay is headqutered in Texas, the US.
The global laboratory chemical reagents market size was valued at over USD 20 billion and projected to grow at a significant CAGR of over 6% during the forecast period 2021 to 2027. The increasing demand from the biotechnology industry is a primary factor to drive the market growth. The rising chemical reagents application and research activity are some other factors to drive the market. Furthermore, increasing investment in research and development activities is projected to fuel the market in next upcoming years. Moreover, increasing usage of laboratory chemical reagents in wastewater treatment is augmenting the market growth. However, the availability of substitutes for these reagents is expected to restrain the market.
MBio Diagnostics, Inc (MBio) is a medical equipment company. It delivers testing systems for the rapid diagnosis and management of multiple diseases simultaneously with the help of its innovative optical technology
MicroTransponder Inc. (MicroTransponder) is a medical device company. It is a spun out from the University of Texas. The company carries out the development of neurostimulation solutions to treat neurological diseases.
Global Transfection Technologies Market By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, In Vivo Transfection), Applications (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming & Differentiation, Stable Cell Line Generation), Geography - Industry Trends and Forecast to 2024
Global Transfection Technologies Market By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, In Vivo Transfection), Applications (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming & Differentiation, Stable Cell Line Generation), Geography - Industry Trends and Forecast to 2024
Manhattan Scientifics, Inc. (Manhattan Scientifics) is a technology developer. It develops, transfers and commercializes technologies. The company develops micro fuel cell technology, which is designed to become a miniature electricity generator that converts hydrogen into electricity by chemical means, for portable electronic devices, including cellular telephones, as a substitute for lithium ion and other batteries in common use. The company through its Metallicum, Inc.
Global nerve regeneration and repair market is registering a healthy CAGR of 12.95% in the forecast period of 2019-2026. This rise in the market value can be attributed to high incidences of nerve injuries globally. There are various technological advancement in the nerve repair technologies. There is a surge in the number of elderly population which is driving the market growth.
MetaStat, Inc., (MetaStat) formerly known as Photovoltaic Solar Cells Inc., is a life science company. It focuses on the development of proprietary clinical diagnostic tests.
Control Medical Technology, LLC (Control Medical Technology) is a US-based development stage medical device company. Control Medical Technology designs, develops and markets medical equipments to assist physicians, nurses, technicians and others.
Beijing Dehaier Medical Technology Co., Ltd. (BDL), is a subsidiary of Dehaier Medical Systems Limited which distributes and provides after sales services of medical equipment in China. The products of the company focuses on respiratory and oxygen homecare.
Title: Slide 1 Last modified by: Ric Schumacher Created Date: 10/9/2006 6:48:41 PM Document presentation format: On-screen Show (4:3) Company: Pressure Biosciences, Inc.
Forticell Bioscience, Inc. Developing Innovative Products To Advance Regenerative Medicine ... This presentation contains forward-looking statements, including, ...
Courtagen Life Sciences, Inc. (Courtagen), formerly known as Avantra Biosciences Corporation, is a life science company. It focuses on offering genomic and proteomic products and services for the treatment of neurological and metabolic disorders. The companys product portfolio consists of POC protein biomarker technologies, namely, Avantra Q400 biomarker workstation and QPDx biochip. These products allow scientists and clinicians to conduct multiplex biomarker analysis for research use only from their lab bench or clinical trial site.
iHealth Lab Inc. (iHealth Lab) is designer and manufacturer of personal healthcare products. The company offers products to test, graph, track and share health information of customers. Its product iHealth wireless body analysis scale can fit with different models of iPhone, iPod touch and iPad.
Request a Sample of this Report @https://whipsmartmi.com/sample/he0559/Single_cell-Analysis-Market The prominent players in the global Single-cell Analysis Market are Becton, Dickinson and Company, Danaher Corporation, Merck Millipore, Qiagen N.V., Thermo Fisher Scientific, Inc, General Electric Company, BARCO, Promega Corporation, Shanghai Goodview Electronics, Fluidigm Corporation, Agilent Technologies, Inc, Nanostring Technologies, Inc., Tecan Group Ltd, Sartorius AG, LUMINEX CORPORATION, Takara Bio Inc., Takara Bio Inc., Fluxion Biosciences and Menarini Silicon Biosystems.
The major competitors covered in the next generation sequencing market report are Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies, Inc., Pacific Biosciences of California Inc. Read More @ http://bit.ly/3r0A7SB
The major competitors covered in the next generation sequencing market report are Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies, Inc., Pacific Biosciences of California Inc. Read More @ http://bit.ly/3r0A7S
Zogenix Inc. Who is Zogenix? Filed March21, 2008 to come public via an $86 million IPO Specialty pharmaceutical company with two proprietary product candidates in ...
Flow Cytometry Market detail information for more Inquiry @ http://goo.gl/4K4k3i . (This is premium report, pricing for which starts at US$4650 Single User PDF) Major players such as BD Biosciences (U.S.), Beckman Coulter Inc. (U.S.), Life Technologies Corporation, and eBioscience, Inc. (U.S.) are adopting several growth strategies such as new product launches, partnerships, agreements, collaborations, joint ventures, mergers and acquisitions in order to keep pace with the evolving industry trends.
The report says that Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.
Nurse call systems Market 2020 Analysis and Review: Nurse Call Systems Market by Equipment – Button-based, Integrated Communication, Mobile, and Intercom for 2020-2030
According to a new market research study titled ‘Synthetic Biology Market to 2025 – Global Analysis and Forecasts by Product, Technology and Application, the global synthetic biology market was valued at US$ 8,244.8 Mn in 2017 and is estimated to reach US$ 56,044.9 Mn by 2025. The report highlights the trends prevalent in the global synthetic biology market and the factors driving the market along with those that act as deterrents to its growth.
Biological seed treatment market Research Report, identifies new revenue opportunity in Crops Segment. The report aims at estimating the market size and future growth of the Farming Industry. Covid-19 impact on Biological Seed Treatment Market
Key market participants identified by the report include Charles River Laboratories International, Inc., Horizon Discovery Group plc, The Jackson Laboratory, Trans Genic Inc, Taconic Biosciences, Inc., Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc., Envigo CRS SA, and Transposagen Biopharmaceuticals, Inc.
needle-free subcutaneous delivery of sumatriptan for the treatment of acute ... elimination half-life ranges from 2 hours (sumatriptan and rizatriptan) to 25 ...
Looking forward, the enteric Disease testing market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/enteric-disease-testing-market
Biofertilizers Market report categorizes the Global Market by Form, Crop Type, Type, Mode of Application, & by Geography. Get detail insights on Covid-19 Impact on Biofertilizers Market, get report today
General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., Siemens AG, Hitachi, Ltd., Positron Corporation, Mediso Ltd., and Yangzhou Kindsway Biotech Co. Ltd. are some of the leading players operating in the global Positron Emission Tomography (PET) scanners market.
State of Israel Ministry of Industry, Trade & Labor Office of the Chief Scientist Canada-Israel Technology Innovation Summit 2011 06-07 July 2011 / Tel-Aviv Renewable ...
Get more information about the market: http://www.imarcgroup.com/dna-sequencing-products-market According to the latest report by IMARC Group, titled “DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global DNA sequencing products market reached a value of more than US$ 3 Billion in 2016. Request a sample report: http://www.imarcgroup.com/request?type=report&id=839&flag=B Browse more reports on Healthcare Industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal
Metabolomx develops and owns all worldwide rights to the breath test for cancer. It uses CSA technology which is a matrix of colored chemical indicators of diverse reactivities incorporated in a nanoporous sol-gel matrix.
Review of New Drug Development Challenges for the Research-Based Industry Kenneth I Kaitin, Ph.D. Director, Tufts Center for the Study of Drug Development
Tissue Transplantation Products and Services Market report categorizes the global report into various segments to provide complete information on Industry Insights, Trends, Market Outlook, and Opportunity Analysis
RECOVERY OF BIOLOGICAL PRODUCTS 10. CANC N MEXICO, 3-8 JUNE 2001. Recovery of Biological Products 10. Welcome to. Canc n. Moctezuma and the gardner of paradise ...
Advantages of the Industry Cluster Approach to Economic Development Mary Jo Waits Morrison Institute for Public Policy Arizona State University Why New Approach to ...
Worldwide Pancreatic Cancer Therapy Market Analysis to 2027 is a specialized and in-depth study of the Pancreatic Cancer Therapy industry with a focus on the global market trend. The report aims to provide an overview of global Pancreatic Cancer Therapy market with detailed market segmentation by product/application and geography. The global Pancreatic Cancer Therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the Pancreatic Cancer Therapy players and offers key trends and opportunities in the market.
Global human microbiome market is expected to rise by 2026, registering a healthy CAGR of 28.2% in the forecast period of 2019-2026. This rise in the market can be attributed to the rise in the advanced technology, increase in the aging population and rise in incidence of chronic diseases.